Correlation Between Surface Oncology and Allogene Therapeutics
Can any of the company-specific risk be diversified away by investing in both Surface Oncology and Allogene Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surface Oncology and Allogene Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Surface Oncology and Allogene Therapeutics, you can compare the effects of market volatilities on Surface Oncology and Allogene Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surface Oncology with a short position of Allogene Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surface Oncology and Allogene Therapeutics.
Diversification Opportunities for Surface Oncology and Allogene Therapeutics
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Surface and Allogene is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Surface Oncology and Allogene Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allogene Therapeutics and Surface Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surface Oncology are associated (or correlated) with Allogene Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allogene Therapeutics has no effect on the direction of Surface Oncology i.e., Surface Oncology and Allogene Therapeutics go up and down completely randomly.
Pair Corralation between Surface Oncology and Allogene Therapeutics
If you would invest 96.00 in Surface Oncology on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Surface Oncology or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 4.35% |
| Values | Daily Returns |
Surface Oncology vs. Allogene Therapeutics
Performance |
| Timeline |
| Surface Oncology |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Allogene Therapeutics |
Surface Oncology and Allogene Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Surface Oncology and Allogene Therapeutics
The main advantage of trading using opposite Surface Oncology and Allogene Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surface Oncology position performs unexpectedly, Allogene Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allogene Therapeutics will offset losses from the drop in Allogene Therapeutics' long position.| Surface Oncology vs. Syros Pharmaceuticals | Surface Oncology vs. Repare Therapeutics | Surface Oncology vs. Personalis | Surface Oncology vs. Evogene |
| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |